Healthcare and life sciences

Hammarskiöld

The team at Hammarskiöld handles a range of matters, from clinical trial agreements and GDPR-related issues, to Administrative Court disputes concerning medicinal products. Noted by clients for her ‘excellent, broad-based expertise’, Malin von Heideken leads the team with her extensive knowledge of commercial cases against government agencies, and is active across the biotech, medical device, and pharma industries. Sofia Falkner is well equipped to advise clients on distribution and merger control mandates, in addition to handling competition investigations and public procurement issues. Timothy Mjällby is a key name for compliance mandates, often assisting with R&D and licensing agreements, and FDI notifications.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Malin von Heideken: pragmatic and client focused. Timothy Mjällby: good intrinsics and very productive.’
‘During a period, where we as a client were put in a stressful situation, Malin von Heideken, Sofia Falkner and their team were very dedicated to our case and were always within reach. They understood the importance of our situation. And even though I perfectly know they have other clients to take care for as well, we never felt this. It was 100% dedication.’
‘Both Malin von Heideken and Sofia Falkner were always available, they very quickly understood our situation and what our needs were. The legal advice they gave us during the situation has been precise, and as an in-house attorney myself, they were good to spar with.’
‘Small and friendly team that is heavily engaged in life sciences work.’
‘I work predominantly with Malin von Heideken who heads up the team. She is engaged in the field and has excellent, broad-based expertise.’

Key clients

Cellcolabs
Sirona Health Solutions
Asker Healthcare Group
Devyser Diagnostics Group
Sigrid Therapeutics
Psomri
Orifarm
EpiEndo Pharmaceuticals
Althea Group
Norgine
Thermo Fisher Scientific
Tietoevry
SHL Medical

Work highlights

Advising an ATMP company with complex regulatory issues concerning an investigation where the legal landscape is somewhat unknown.
Represented Orifarm Generics in proceedings against the Swedish Medical Products Agency concerning one of its products before the Supreme Administrative Court.
Advised a medical device company on an AI collaboration project in its field of activity.